Bapurao Surnar

Bapurao Surnar

Auto-generated profile, based on publicly available information

Bapurao Surnar

NanoTherapeutics Research Laboratory, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in ACS Nano
Verified
Journal Article
Closed access
DKDavid Kolb
David Kolb
NKNagesh Kolishetti
Nagesh Kolishetti
BSBapurao Surnar
Bapurao Surnar
SSShrita Sarkar
Shrita Sarkar
SGSubham Guin
Subham Guin
SDShanta Dhar
Shanta Dhar


30 September 2015 in Nanoscale
Verified
Journal Article
Open access
PDF file
BSBapurao Surnar
Bapurao Surnar
KSKavita Sharma
Kavita Sharma
MJManickam Jayakannan
Manickam Jayakannan
Platinum drug delivery against the detoxification of cytoplasmic thiols is urgently required for achieving efficacy in breast cancer treatment that is over expressed by glutathione (GSH, thiol-oligopeptide). GSH-resistant polymer–cisplatin core–shell nanoparticles were custom designed based on biodegradable carboxylic functional polycaprolactone (PCL)-block-poly(ethylene glycol) diblock copolymers. The core of the nanoparticle was fixed as 100 carboxylic units and the shell part was varied using various molecular weight poly(ethylene glycol) monomethyl ethers (MW of PEGs = 100–5000 g mol−1) as initiator in the ring-opening polymerization. The complexation of cisplatin aquo species with the diblocks produced core–shell nanoparticles of 75 nm core with precise size control the particles up to 190 nm. The core–shell nanoparticles were found to be stable in saline solution and PBS and they exhibited enhanced stability with increase in the PEG shell thickness at the periphery. The hydrophobic PCL layer on the periphery of the cisplatin core behaved as a protecting layer against the cytoplasmic thiol residues (GSH and cysteine) and exhibited <5% of drug detoxification. In vitro drug-release studies revealed that the core–shell nanoparticles were ruptured upon exposure to lysosomal enzymes like esterase at the intracellular compartments. Cytotoxicity studies were performed both in normal wild-type mouse embryonic fibroblast cells (Wt-MEFs), and breast cancer (MCF-7) and cervical cancer (HeLa) cell lines. Free cisplatin and polymer drug core–shell nanoparticles showed similar cytotoxicity effects in the HeLa cells. In MCF-7 cells, the free cisplatin drug exhibited 50% cell death whereas complete cell death (100%) was accomplished by the polymer–cisplatin core–shell nanoparticles. Confocal microscopic images confirmed that the core–shell nanoparticles were taken up by the MCF-7 and HeLa cells and they were accumulated both at the cytoplasm as well at peri-nuclear environments. The present investigation lays a new foundation for the polymer-based core–shell nanoparticles approach for overcoming detoxification in platinum drugs for the treatment of GSH over-expressed breast cancer cells.

11 October 2019 in ACS Nano
Verified
Journal Article
Closed access
BSBapurao Surnar
Bapurao Surnar
MKMohammad Z. Kamran
Mohammad Z. Kamran
ASAnuj S. Shah
Anuj S. Shah
UBUttara Basu
Uttara Basu
NKNagesh Kolishetti
Nagesh Kolishetti
SDShanta Dhar
Shanta Dhar

22 December 2015 in Biomacromolecules
Verified
Journal Article
Closed access
SKSmita Kashyap
Smita Kashyap
NSNitesh Singh
Nitesh Singh
BSBapurao Surnar
Bapurao Surnar
MJManickam Jayakannan
Manickam Jayakannan

10 December 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BSBapurao Surnar
Bapurao Surnar
UBUttara Basu
Uttara Basu
BBBhabatosh Banik
Bhabatosh Banik
ANIS AHMADANIS AHMAD
ANIS AHMAD
BMBrian Marples
Brian Marples
SDShanta Dhar
Shanta Dhar
The success of nanoparticle-mediated delivery of antioxidant and antiinflammatory-based neuroprotectants to the brain to improve neuronal functions in neurodegenerative diseases has demonstrated lesser impact instead of achieving its full potential. We hypothesized that these failures were due to a combination of parameters, such as: (i) unavailability of a delivery vehicle, which can reproducibly and efficiently transport through the brain capillary endothelium; (ii) inefficient uptake of therapeutic nanoparticles in the neuronal cell population; and (iii) limited ability of a single nanoparticle to cross the two most-impermeable biological barriers, the blood–brain barrier and mitochondrial double membrane, so that a nanoparticle can travel through the brain endothelial barrier to the mitochondria of target cells where oxidative damage is localized. Herein, we demonstrate optimization of a biodegradable nanoparticle for efficient brain accumulation and protection of astrocytes from oxidative damage and mitochondrial dysfunctions to enhance the neuroprotection ability of astrocytes toward neurons using neurodegeneration characteristics in SOD1G93A rats. This biodegradable nanomedicine platform with the ability to accumulate in the brain has the potential to bring beneficial effects in neurodegenerative diseases by modulating the stars, astrocytes in the brain, to enhance their neuroprotective actions. Significance Neurodegenerative disorders touch many lives in the form of various diseases. Therapeutic interventions of such disorders are limited due to the difficulty in reaching the neurons by crossing the impermeable blood–brain barrier. Scientists have created nanoscopic particles to take therapeutics to the brain; however, the results have not been very encouraging due to the inefficient ability of the nanoplatforms in crossing the blood–brain barrier and to accumulate in the target neuron cells effectively as uptake of nanomaterials by neurons is difficult to achieve. We provide a biodegradable nanoparticle platform with efficient brain astrocyte accumulation properties to provide an alternative approach to tackle neurodegenerative processes by improving and enhancing astrocyte’s natural protection ability toward neurons for neuromedicine.